“The pharmaceutical company boss under fire for increasing the price of the drug Daraprim by more than 5,000 percent said Tuesday he will lower the cost of the life-saving medication.
“Martin Shkreli did not say what the new price would be, but expected a determination to be made over the next few weeks.
“He told NBC News that the decision to lower the price was a reaction to outrage over the increase in the price of the drug from $13.50 to $750 per pill.
“Turing Pharmaceuticals of New York bought the drug from Impax Laboratories in August for $55 million and raised the price.
“Shkreli said Tuesday the price would be lowered to allow the company to break even or make a smaller profit.”
Read more at NBC News
